Circulation: Cardiovascular Interventions最新文献

筛选
英文 中文
Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests. 冠状窦减速器对功能应激试验中缺血程度的影响。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-13 DOI: 10.1161/CIRCINTERVENTIONS.126.017002
Sheizaf Gefen, Gil Mashiah, Yoav Perez, Elina Stsiapanava, Miri Revivo, Haim Shmilovich, Shmuel Banai, Jeremy Ben-Shoshan, Maayan Konigstein
{"title":"Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests.","authors":"Sheizaf Gefen, Gil Mashiah, Yoav Perez, Elina Stsiapanava, Miri Revivo, Haim Shmilovich, Shmuel Banai, Jeremy Ben-Shoshan, Maayan Konigstein","doi":"10.1161/CIRCINTERVENTIONS.126.017002","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017002","url":null,"abstract":"<p><strong>Background: </strong>The coronary sinus reducer is an established therapy for patients with refractory angina due to obstructive coronary artery disease who are not candidates for further revascularization. Although symptomatic benefits are well documented, its effect on objective measures of ischemia remains unclear. This study aimed to evaluate the association between coronary sinus reducer implantation and inducible myocardial ischemia assessed by functional stress testing.</p><p><strong>Methods: </strong>We retrospectively analyzed a prospectively maintained registry of consecutive patients undergoing coronary sinus reducer implantation between 2011 and 2024. Baseline assessment included Canadian Cardiovascular Society angina class, 6-minute walk test, stress echocardiography, and dipyridamole single-photon emission computed tomography imaging, repeated at 6 months. Coprimary outcomes were changes in stress wall motion score index and in the proportion of patients with moderate or severe ischemia on single-photon emission computed tomography. Clinical nonresponders were defined as no improvement in Canadian Cardiovascular Society class at 12 months.</p><p><strong>Results: </strong>Among 153 treated patients, 118 had complete imaging data. Median stress wall motion score index improved from 1.38 to 1.23 (<i>P</i><0.001), and stress left ventricular ejection fraction increased from 55% to 60% (<i>P</i>=0.019). The proportion of patients with moderate or severe ischemia on single-photon emission computed tomography decreased from 52% to 24% (<i>P</i><0.001). The summed difference score, available in 45 patients, did not change significantly. Clinically, 86% improved by ≥1 Canadian Cardiovascular Society class at 6 months.</p><p><strong>Conclusions: </strong>Coronary sinus reducer implantation was associated with reduced inducible ischemia on stress echocardiography and with clinical improvement. The proportion of patients with moderate or severe ischemia on single-photon emission computed tomography decreased following Reducer implantation.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e017002"},"PeriodicalIF":7.2,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonculprit Lesion Complexity and Timing of Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: Insights From the BIOVASC Trial. 急性冠状动脉综合征和多血管疾病患者的非罪魁祸首病变复杂性和完全血运重建时间:来自BIOVASC试验的见解
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-13 DOI: 10.1161/CIRCINTERVENTIONS.126.017520
Gianmaria Scherillo, Jacob J Elscot, Johan Bennett, Manel Sabaté, Giovanni Esposito, Eric Boersma, Wijnand K den Dekker, Nicolas M Van Mieghem, Roberto Diletti
{"title":"Nonculprit Lesion Complexity and Timing of Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: Insights From the BIOVASC Trial.","authors":"Gianmaria Scherillo, Jacob J Elscot, Johan Bennett, Manel Sabaté, Giovanni Esposito, Eric Boersma, Wijnand K den Dekker, Nicolas M Van Mieghem, Roberto Diletti","doi":"10.1161/CIRCINTERVENTIONS.126.017520","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017520","url":null,"abstract":"<p><strong>Background: </strong>The optimal timing of complete revascularization for patients with acute coronary syndrome, multivessel disease and complex nonculprit coronary lesions (NCL) remains unclear.</p><p><strong>Methods: </strong>The BIOVASC trial randomized patients with acute coronary syndrome and multivessel disease to immediate complete revascularization and staged complete revascularization. The primary end point was a composite of all-cause mortality, myocardial infarction, unplanned ischemia-driven revascularization, or cerebrovascular events at 2-year follow-up. In this exploratory post hoc analysis, patients were classified as having complex NCL if at least 1 nonculprit lesion met the following criteria: true bifurcation; severe calcification; lesion length >20 mm; aorto-ostial lesion; left main lesion. We aimed to compare a strategy of immediate complete revascularization and staged complete revascularization in patients presenting with acute coronary syndrome and multivessel disease with complex NCL. Moreover, we sought to compare patients with complex and noncomplex NCLs in terms of clinical outcomes.</p><p><strong>Results: </strong>Among the 1525 patients enrolled in the BIOVASC trial, 550 (36.1%) had a complex NCL. The presence of a complex NCL was associated with a significantly higher incidence of the primary end point compared with noncomplex NCL (adjusted hazard ratio, 1.49 [95% CI, 1.11-2.02]; <i>P</i>=0.01), including spontaneous myocardial infarction (adjusted hazard ratio, 1.86 [95% CI, 1.12-3.09]; <i>P</i>=0.02). In patients with complex NCL, the cumulative incidence of the primary end point was 15.7% in the immediate complete revascularization group and 17.5% in the staged complete revascularization group (hazard ratio, 0.86 [95% CI, 0.57-1.31]; <i>P</i>=0.49). No significant interaction was observed between the presence of a complex NCL and revascularization strategy for the primary end point (<i>P</i> for interaction=0.40).</p><p><strong>Conclusions: </strong>In patients with acute coronary syndrome and multivessel disease, patients with complex NCL experienced worse clinical outcomes at 2-year follow-up, driven by higher rates of myocardial infarction. However, no statistically significant interaction was observed between NCL complexity and the effect of immediate complete revascularization versus staged complete revascularization.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT03621501.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e017520"},"PeriodicalIF":7.2,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response by Heil et al to Letter Regarding Article, "Artificial Intelligence-Derived Volumetric High-Risk Plaque Features Are Predominantly Located Proximal to Maximal Luminal Stenosis". Heil等人对关于文章“人工智能衍生的体积高危斑块特征主要位于最大管腔狭窄近端”的信件的回应。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-13 DOI: 10.1161/CIRCINTERVENTIONS.126.017652
Leah E Heil, Thijs J Luttikholt, Niels van Royen, Rick H J A Volleberg
{"title":"Response by Heil et al to Letter Regarding Article, \"Artificial Intelligence-Derived Volumetric High-Risk Plaque Features Are Predominantly Located Proximal to Maximal Luminal Stenosis\".","authors":"Leah E Heil, Thijs J Luttikholt, Niels van Royen, Rick H J A Volleberg","doi":"10.1161/CIRCINTERVENTIONS.126.017652","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017652","url":null,"abstract":"","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e017652"},"PeriodicalIF":7.2,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter by Doğan et al Regarding Article, "Artificial Intelligence-Derived Volumetric High-Risk Plaque Features Are Predominantly Located Proximal to Maximal Luminal Stenosis". Doğan等人关于文章“人工智能衍生的容积高危斑块特征主要位于最大管腔狭窄近端”的信。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-13 DOI: 10.1161/CIRCINTERVENTIONS.126.017582
Abdullah Doğan, Kaan Gökçe, Berkay Serter
{"title":"Letter by Doğan et al Regarding Article, \"Artificial Intelligence-Derived Volumetric High-Risk Plaque Features Are Predominantly Located Proximal to Maximal Luminal Stenosis\".","authors":"Abdullah Doğan, Kaan Gökçe, Berkay Serter","doi":"10.1161/CIRCINTERVENTIONS.126.017582","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017582","url":null,"abstract":"","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e017582"},"PeriodicalIF":7.2,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Volumes and Outcomes of Early-Career Operators Performing TAVR in the United States. 美国早期职业作业者实施TAVR的病例数量和结果。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-11 DOI: 10.1161/CIRCINTERVENTIONS.126.016960
Husam M Salah, Pratik Manandhar, Suzanne Baron, Wayne Batchelor, David Cohen, J Kevin Harrison, G Chad Hughes, Angela Lowenstern, Andres M Pineda, Yuri B Pride, Vinod H Thourani, Andrew M Vekstein, Andrew Wang, Zachary Wegermann, Michael N Young, Sreekanth Vemulapalli, Jennifer A Rymer
{"title":"Case Volumes and Outcomes of Early-Career Operators Performing TAVR in the United States.","authors":"Husam M Salah, Pratik Manandhar, Suzanne Baron, Wayne Batchelor, David Cohen, J Kevin Harrison, G Chad Hughes, Angela Lowenstern, Andres M Pineda, Yuri B Pride, Vinod H Thourani, Andrew M Vekstein, Andrew Wang, Zachary Wegermann, Michael N Young, Sreekanth Vemulapalli, Jennifer A Rymer","doi":"10.1161/CIRCINTERVENTIONS.126.016960","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.016960","url":null,"abstract":"<p><strong>Background: </strong>Operator experience is a key determinant of outcomes after transcatheter aortic valve replacement (TAVR). However, whether early-career operators achieve comparable results to more experienced peers is unknown. Herein, we evaluate case volumes, patient risk profiles, and 30-day outcomes of early-career versus non-early-career operators performing TAVR in the United States.</p><p><strong>Methods: </strong>Using the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry, we identified isolated TAVR procedures from October 2011 through March 2024. Early-career status was defined as ≤5 years in independent practice (based on board certification or first TAVR date); non-early-career status was >5 years. Multivariable hierarchical models adjusted for patient-, procedural-, operator-, and site-level factors, including annualized institutional TAVR volume, while accounting for clustering of procedures within operators and operators within sites. Primary outcomes were 30-day mortality and a composite of death, stroke, major bleeding, stage III acute kidney injury, or moderate-to-severe paravalvular leak.</p><p><strong>Results: </strong>A total of 634 723 TAVR procedures were performed by 3126 operators across 847 sites, including 90 376 (14.2%) by early-career operators. Median annualized lifetime volume was lower for early-career operators (13 [interquartile range, 5-31] versus 19 [interquartile range, 7-42] cases per year; <i>P</i><0.001). After adjustment, 30-day mortality was similar between early-career and non-early-career operators (2.38% versus 2.44%; risk ratio, 0.97 [95% CI, 0.92-1.01]; <i>P</i>=0.293), whereas the composite end point was lower among early-career operators (11.19% versus 11.77%; risk ratio, 0.95 [95% CI, 0.93-0.98]; <i>P</i><0.001).</p><p><strong>Conclusions: </strong>In a national TAVR registry, early-career operators performed fewer cases but achieved similar 30-day mortality and a modestly lower adjusted composite event rate relative to more experienced peers. These findings suggest that within the structured, team-based environment of contemporary TAVR programs, early-career status alone is not associated with inferior procedural outcomes and should not be viewed as a barrier to independent practice.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e016960"},"PeriodicalIF":7.2,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter Mitral Cerclage Ventriculoplasty: 5-Year Outcomes. 经导管二尖瓣环绕心室成形术:5年结果。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-11 DOI: 10.1161/CIRCINTERVENTIONS.126.017202
Toby Rogers, Adam B Greenbaum, Vasilis C Babaliaros, Jason R Foerst, Jaffar M Khan, Christopher G Bruce, Annette M Stine, Xin Tian, Robert J Lederman
{"title":"Transcatheter Mitral Cerclage Ventriculoplasty: 5-Year Outcomes.","authors":"Toby Rogers, Adam B Greenbaum, Vasilis C Babaliaros, Jason R Foerst, Jaffar M Khan, Christopher G Bruce, Annette M Stine, Xin Tian, Robert J Lederman","doi":"10.1161/CIRCINTERVENTIONS.126.017202","DOIUrl":"10.1161/CIRCINTERVENTIONS.126.017202","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter mitral cerclage ventriculoplasty places a circumferential tensioning loop around the base of the left ventricle to reduce mitral annular dimensions and reshape ventricular geometry in patients with functional mitral regurgitation and heart failure. Early experience demonstrated reductions in mitral regurgitation and improvements in heart failure symptoms.</p><p><strong>Methods: </strong>The National Heart, Lung, and Blood Institute Division of Intramural Research Transcatheter Mitral Cerclage Ventriculoplasty Early Feasibility Study was an investigator-initiated, prospective, multicenter study. Between 1 and 5 years, vital status, serious adverse events, routine clinical documentation, and site-reported transthoracic echocardiography findings were collected.</p><p><strong>Results: </strong>Nineteen procedures were attempted in 18 participants (63% heart failure with reduced ejection fraction, 37% heart failure with preserved ejection fraction). Median age was 73 years, and 63% were female. Kaplan-Meier estimated 5-year survival was 57%. One participant underwent left ventricular assist device implantation after 2 years, and 1 participant underwent mitral transcatheter edge-to-edge repair after 3 years; none underwent heart transplantation. The study was suspended after complete heart block developed in 6 participants, including 4 requiring new cardiac implantable electronic devices. Among participants with available follow-up echocardiography, site-reported imaging demonstrated mitral regurgitation reduction and improved left ventricular ejection fraction through 5 years. Symptomatic improvement was most apparent during the first year and attenuated thereafter.</p><p><strong>Conclusions: </strong>Cerclage ventriculoplasty was associated with mitral regurgitation reduction and improved ventricular function among participants with available long-term follow-up. Symptomatic benefit was greatest during the first year and diminished thereafter, suggesting that favorable remodeling may not fully offset progression of the underlying cardiomyopathy.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT03929913.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e017202"},"PeriodicalIF":7.2,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13758946/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study. 美国射频肾去神经治疗的有效性:来自SPYRAL AFFIRM研究的六个月主要终点结果。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-03 DOI: 10.1161/CIRCINTERVENTIONS.126.017422
David E Kandzari, Kazuomi Kario, Michael A Weber, Raymond R Townsend, Roland E Schmieder, Michael Böhm, Kostantinos Tsioufis, Robert Stoler, David P Lee, Frank Navetta, Barry Bertolet, Srinivasa Potluri, Shukri David, Debbie L Cohen, Te-Hsin Lung, Kelsey Anderson, Julie Carvelli, Felix Mahfoud
{"title":"Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study.","authors":"David E Kandzari, Kazuomi Kario, Michael A Weber, Raymond R Townsend, Roland E Schmieder, Michael Böhm, Kostantinos Tsioufis, Robert Stoler, David P Lee, Frank Navetta, Barry Bertolet, Srinivasa Potluri, Shukri David, Debbie L Cohen, Te-Hsin Lung, Kelsey Anderson, Julie Carvelli, Felix Mahfoud","doi":"10.1161/CIRCINTERVENTIONS.126.017422","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017422","url":null,"abstract":"<p><strong>Background: </strong>Radiofrequency renal denervation (RDN) is a guideline-recommended therapy for uncontrolled hypertension. SPYRAL AFFIRM is a single-arm, postapproval study assessing the efficacy and safety of radiofrequency RDN using the Symplicity Spyral catheter. We report the 6-month primary end point results in the SPYRAL AFFIRM US population.</p><p><strong>Methods: </strong>Enrolled patients had an office systolic/diastolic blood pressure (BP) ≥140/90 mm Hg and a home systolic BP ≥135 mm Hg. Patients with type 1 diabetes, poorly controlled type 2 diabetes (HbA1c >8.0%), or an estimated glomerular filtration rate <45 mL/min per 1.73 m<sup>2</sup> were excluded. The primary end point was the 6-month change in office systolic BP from baseline compared with a prespecified performance goal (-6.0 mm Hg).</p><p><strong>Results: </strong>Among 594 patients treated in the AFFIRM study from 73 US clinical sites, baseline clinical characteristics included: mean (±SD) age, 57±12 years; female, 45%; African American, 27%; Hispanic, 11%; type 2 diabetes, 19%; and mean estimated glomerular filtration rate, 79±20 mL/min per 1.73m<sup>2</sup>. Baseline systolic/diastolic office, home, and 24-hour ambulatory BP (mm Hg) were 169±21/106±13, 158±17/101±13, and 151±18/96±13, respectively. Patients were prescribed an average of 3.6±2.0 antihypertensive medications at baseline that remained unchanged through 6 months. Six months after RDN, the change in systolic BP (mm Hg) was -18.2±22.0, -9.4±13.8, and -9.7±16.8 for office, home, and 24-hour ambulatory measures, respectively (<i>P</i><0.001 compared with baseline). Adverse clinical events through 6 months were uncommon.</p><p><strong>Conclusions: </strong>In this US postapproval study, the primary end point was met with significant BP reductions following radiofrequency RDN consistent across different measures. In a broader patient population with uncontrolled hypertension, these results reaffirm the safety and efficacy of radiofrequency RDN.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT05198674.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e017422"},"PeriodicalIF":7.2,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of Virtual Circle Method and Valve-to-Aorta Distance Change After Redo-TAVR: Multicenter Paired CT Analysis. 多中心配对CT分析:Redo-TAVR术后虚拟圆法与瓣膜-主动脉距离变化的准确性。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-03 DOI: 10.1161/CIRCINTERVENTIONS.126.017259
Miho Fukui, Stephanie L Sellers, Ole De Backer, Santiago A Garcia, Sachin S Goel, David Meier, Yusuke Kobari, Arif Khokhar, Sachiyo Ono, Gustavo Mendez Hirata, Mangesh Kritya, John G Webb, Michael Reardon, Vinayak N Bapat
{"title":"Accuracy of Virtual Circle Method and Valve-to-Aorta Distance Change After Redo-TAVR: Multicenter Paired CT Analysis.","authors":"Miho Fukui, Stephanie L Sellers, Ole De Backer, Santiago A Garcia, Sachin S Goel, David Meier, Yusuke Kobari, Arif Khokhar, Sachiyo Ono, Gustavo Mendez Hirata, Mangesh Kritya, John G Webb, Michael Reardon, Vinayak N Bapat","doi":"10.1161/CIRCINTERVENTIONS.126.017259","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017259","url":null,"abstract":"<p><strong>Background: </strong>The virtual circle method is currently used in preprocedural computed tomography planning for Redo-transcatheter aortic valve (TAV) replacement to simulate the predicted outer boundary of the index TAV and the valve-to-aorta distance for coronary risk assessment, yet its accuracy against postprocedural observations has not been evaluated. This study aimed to assess the accuracy of the virtual circle method in predicting index TAV expansion and coronary risk following a second TAV implantation using paired preprocedural and postprocedural computed tomography in patients undergoing Redo-TAV replacement.</p><p><strong>Methods: </strong>This multicenter retrospective study included 58 patients who underwent Redo-TAV replacement at 5 sites with paired preprocedural and postprocedural cardiac computed tomography. Three valve combinations were analyzed: Evolut-in-SAPIEN (n=17), SAPIEN-in-SAPIEN (n=13), and SAPIEN-in-Evolut (n=28). Index TAV frame expansion was quantified by area- or perimeter-derived diameter change. Accuracy of the virtual circle method was defined as a diameter difference within ±1 mm between predicted and observed index TAV frame diameter.</p><p><strong>Results: </strong>In the Evolut-in-SAPIEN combination, meaningful index SAPIEN frame expansion occurred only with effective pre/postdilatation, whereas in both the SAPIEN-in-SAPIEN and SAPIEN-in-Evolut combinations, consistent frame expansion was observed regardless of dilatation. Changes in index frame diameter corresponded inversely to changes in valve-to-aorta distance. In the SAPIEN-in-Evolut combination, expansion was governed chiefly by implant position and sizing strategy. Across all combinations in which the virtual circle method was applicable (n=53), accurate prediction was achieved in 31 patients (58.5%), with overestimation in 14 (26.4%) and underestimation in 8 (15.1%).</p><p><strong>Conclusions: </strong>The virtual circle method provided an accurate or conservative (overestimating) estimate of index TAV expansion and coronary risk in the majority of patients (85%), supporting its clinical utility for Redo-TAVR planning. The remaining 15% showed underestimation of modest magnitude (median, 1.3 mm), occurring predominantly in patients who underwent predilatation and postdilatation, warranting heightened caution in borderline coronary anatomy when dilatation strategies are employed.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":"e017259"},"PeriodicalIF":7.2,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Bailout Mechanical Circulatory Support Use for Hemodynamic Collapse During PCI: The ORACLE Score. 预估PCI期间使用机械循环支持治疗血流动力学崩溃:ORACLE评分。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-03 DOI: 10.1161/CIRCINTERVENTIONS.126.017503
Enrico Poletti, Milan Seth, Primero Ng, Christine J Chung, David Elison, Zachary L Steinberg, William L Lombardi, Eric Cantey, David E Hamilton, Hitinder S Gurm, Lorenzo Azzalini
{"title":"Prediction of Bailout Mechanical Circulatory Support Use for Hemodynamic Collapse During PCI: The ORACLE Score.","authors":"Enrico Poletti, Milan Seth, Primero Ng, Christine J Chung, David Elison, Zachary L Steinberg, William L Lombardi, Eric Cantey, David E Hamilton, Hitinder S Gurm, Lorenzo Azzalini","doi":"10.1161/CIRCINTERVENTIONS.126.017503","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017503","url":null,"abstract":"<p><p><b>Background:</b> Bailout mechanical circulatory support (MCS) may be used in the setting of intraprocedural hemodynamic collapse during percutaneous coronary intervention (PCI). We developed and externally validated a simple risk prediction model for bailout MCS use for hemodynamic collapse during PCI. <b>Methods:</b> Consecutive patients undergoing PCI at a tertiary hospital between 2018 and 2025 were included in the derivation cohort (n=6,931), after excluding cases of salvage PCI and procedures performed with pre-existing or prophylactic MCS. The primary endpoint was bailout MCS use for hemodynamic collapse. A multivariable Firth logistic regression model was developed, internally validated, and translated into a simplified integer-based risk score (ORACLE). External validation was performed in 214,877 PCIs from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry. <b>Results:</b> The incidence of bailout MCS was 1.4% in the derivation cohort. Six variables (non-elective presentation, systolic blood pressure, chronic heart failure, prior PCI, rotational/orbital atherectomy, and left main PCI) independently predicted the primary endpoint. The regression model demonstrated good discrimination both in the derivation (area under the curve [AUC] 0.817; 95% confidence interval [CI] 0.774-0.860) and external validation (AUC 0.761; 95% CI 0.753-0.770) cohorts. The simplified ORACLE score preserved most of the discriminatory performance of the full model (AUC 0.791 in the derivation cohort and 0.718 in the external validation cohort) and effectively stratified patients, with observed bailout MCS rates ranging from 0.4% in the low-risk category to 8.7% in the high-risk group, with similar findings in the external validation cohort. Discrimination was consistent across clinically relevant subgroups. Negative predictive value was >99% in both the derivation and external validation cohorts. <b>Conclusions:</b>: ORACLE is a simple score to estimate the risk of bailout MCS use for hemodynamic collapse during PCI, which may support preprocedural risk assessment.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of CKD and Hemodialysis on Treatment of Severely Calcified Lesions: The ECLIPSE Trial. CKD和血液透析对严重钙化病变治疗的影响:ECLIPSE试验。
IF 7.2 1区 医学
Circulation: Cardiovascular Interventions Pub Date : 2026-11-02 DOI: 10.1161/CIRCINTERVENTIONS.126.017556
Pratheesh George, Krishna Santosh Vemuri, Richard A Shlofmitz, Suhail Dohad, Thom Dahle, Andres M Pineda, Kendrick A Shunk, Carlye Kraemer, Philippe Généreux, Ajay J Kirtane, Gregg W Stone
{"title":"Impact of CKD and Hemodialysis on Treatment of Severely Calcified Lesions: The ECLIPSE Trial.","authors":"Pratheesh George, Krishna Santosh Vemuri, Richard A Shlofmitz, Suhail Dohad, Thom Dahle, Andres M Pineda, Kendrick A Shunk, Carlye Kraemer, Philippe Généreux, Ajay J Kirtane, Gregg W Stone","doi":"10.1161/CIRCINTERVENTIONS.126.017556","DOIUrl":"https://doi.org/10.1161/CIRCINTERVENTIONS.126.017556","url":null,"abstract":"<p><p><b>Background:</b> Chronic kidney disease (CKD) and coronary calcification increase risk for adverse events following drug-eluting stent (DES) implantation. We evaluated whether outcomes following vessel preparation with orbital atherectomy (OA) versus balloon angioplasty (BA) vary according to CKD. <b>Methods:</b> This pre-specified CKD sub-analysis of the prospective, multicenter ECLIPSE trial evaluated 2,001 patients with severely calcified lesions randomized to OA versus BA prior to DES. Independent predictors of two-year target-vessel failure (TVF)-a composite of cardiac death, target-vessel myocardial infarction (TV-MI), or ischemia-driven target-vessel revascularization (ID-TVR)-were determined using multivariable Cox proportional hazards modeling. <b>Results:</b> CKD (eGFR <60 mL/min/1.73m² or hemodialysis) was present in 694 (34.7%) patients; 112 required hemodialysis. Two-year TVF was significantly higher with versus without CKD (21.2% vs. 11.6%; p<0.001), driven by increased cardiac death and ID-TVR. Hemodialysis independently predicted TVF (adjusted HR 2.14, 95% CI 1.30-3.53; p=0.003), whereas reduced eGFR alone did not (p=0.070). In patients on hemodialysis, OA versus BA was associated with higher rates of TVF (52.3% vs. 30.7%; adjusted HR 2.50, 95% CI 1.16-5.41; P=0.020), driven by higher rates of TV-MI and ID-TVR, whereas TVF was similar after OA versus BA in patients not on hemodialysis (13.5% vs. 13.1%; adjusted HR 1.05, 95% CI 0.81-1.35; P=0.730); however, the interaction between treatment assignment and hemodialysis status was not significant (Pint=0.244). <b>Conclusions:</b> CKD remains a major predictor of adverse outcomes after DES implantation in severely calcified lesions, with the highest risks in patients on hemodialysis. In the ECLIPSE trial, higher two-year rates of TVF were observed after vessel preparation with OA compared with BA in patients on hemodialysis but not in patients with CKD not on hemodialysis or in those without CKD. Given the modest hemodialysis subgroup size and non-significant interaction testing, confirmation of these findings in additional studies is warranted.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":" ","pages":""},"PeriodicalIF":7.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书